SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (1119)2/18/1998 1:33:00 PM
From: Instock  Read Replies (1) | Respond to of 2173
 
Henry: Wish this kind of News would make it on to Yahoo! What News service was this from? Have any comments about the press release?

Thanks

Instock



To: Henry Niman who wrote (1119)2/18/1998 8:01:00 PM
From: D.Right  Read Replies (1) | Respond to of 2173
 
Dear Henry:

I believe most people know the 75% number from last Aug. What we are talking about now is the same 75% people were still on pramlintide as of a month ago when AMLN made their presentations at the H&Q Conf. There is a five months difference. The duration is what the news is. It looks like most the patients don't mind hang on to the drug for long term use.

D.Right

PS: The rat cancer data by LGND is really impressive, good luck.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News